Journal
VIRUSES-BASEL
Volume 11, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/v11030265
Keywords
bacteriophages; phage therapy; antibiotic resistance; Pseudomonas aeruginosa; Escherichia coli; Staphylococcus aureus; Brussels; Belgium
Categories
Funding
- Royal Higher Institute for Defence [HFM 15-5]
Ask authors/readers for more resources
There is a growing interest in phage therapy as a complementary tool against antimicrobial resistant infections. Since 2007, phages have been used sporadically to treat bacterial infections in well-defined cases in the Queen Astrid military hospital (QAMH) in Brussels, Belgium. In the last two years, external requests for phage therapy have increased significantly. From April 2013 to April 2018, 260 phage therapy requests were addressed to the QAMH. Of these 260 requests, only 15 patients received phage therapy. In this paper, we analyze the phage therapy requests and outcomes in order to improve upon the overall capacity for phage therapy at the QAMH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available